Novartis AG

NYSE:NVSHealthcare

$150.20−0.28%At closeAt close · Tue 20 Oct · ≈ AED 551.61 · Market cap $276.89B · Next earnings Tue 27 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	69.7%	73.3%	73.4%	73.3%	75.2%	75.0%	—	—
Operating margin	20.3%	22.9%	18.3%	20.9%	28.1%	31.2%	31.2%	+0.0 pts
Net margin	16.2%	54.6%	16.0%	31.8%	23.1%	25.6%	25.6%	+0.0 pts
EBITDA margin	34.5%	70.3%	33.8%	39.1%	40.1%	41.9%	—	—
Return on equity	14.3%	35.5%	11.7%	31.8%	27.1%	30.5%	30.2%	−0.3 pts
Return on assets	6.1%	18.2%	5.9%	14.9%	11.7%	12.2%	12.2%	+0.0 pts
Return on capital employed	10.2%	9.9%	8.9%	13.3%	19.8%	19.3%	—	—
Debt / equity	0.7×	0.5×	0.5×	0.6×	0.7×	0.8×	0.8×	−0.9%
Debt / assets	28.6%	23.5%	23.8%	26.4%	30.6%	32.0%	—	—
Interest coverage	11.0×	11.1×	9.5×	11.2×	14.0×	14.4×	—	—
Current ratio	0.9×	1.5×	1.3×	1.2×	1.0×	1.1×	1.1×	+0.0%
Quick ratio	0.7×	1.3×	1.0×	0.9×	0.8×	0.9×	—	—
Cash ratio	0.3×	0.4×	0.3×	0.5×	0.4×	0.4×	0.4×	+0.0%
Asset turnover	0.4×	0.3×	0.4×	0.5×	0.5×	0.5×	—	—
Inventory turnover	2.1×	1.8×	1.6×	2.1×	2.2×	2.2×	—	—
Receivables turnover	5.5×	4.6×	4.4×	5.0×	6.3×	5.0×	—	—
Dividend payout	86.6%	30.7%	107.9%	48.9%	63.8%	55.9%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.